Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2015-11-01 Regulatory Filings
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
Appendix 3Y 2 pages 59.6KB
Regulatory Filings
2015-11-01 English
Appendix 4C - 30 September 2015 11 pages 1.9MB
Regulatory Filings
2015-10-28 English
Notice of 2015 AGM 19 pages 4.7MB
Regulatory Filings
2015-10-26 English
ASX Announcement - CFO Transition 8 pages 139.7KB
Board/Management Information Classification · 100% confidence The document is an announcement dated 6 October 2015 from Genetic Technologies Limited regarding a change in the Chief Financial Officer (CFO). It details the appointment of a new CFO and the transition period with the outgoing CFO. The content focuses solely on management change without any financial data, report content, or regulatory filings. The document is approximately 15,000 characters but is a straightforward announcement of a management change. There are no indications of financial results, audit information, or other report types. Therefore, the document fits best under the category of Board/Management Information (MANG), which covers announcements of changes in senior management roles such as CFO appointments.
2015-10-05 English
Annual Report 2015 85 pages 3.0MB
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2015' for Genetic Technologies and contains detailed sections typical of an annual report, including Chairman and CEO's message, Board of Directors and Senior Management, consolidated financial statements (balance sheet, cash flows, changes in equity), notes to financial statements, directors' declaration, auditor's report, directors' report, corporate governance statement, and auditor's independence declaration. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The content includes comprehensive financial and operational information for the fiscal year 2015, consistent with an official yearly report covering company activity and full financial performance. Therefore, the document fits the definition of an Annual Report (10-K). FY 2015
2015-09-23 English
Appendix 4G and Corporate Governance Statement 26 pages 5.4MB
Regulatory Filings
2015-09-23 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.